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Characterization of the Mupirocin Biosynthesis Gene
Cluster from Pseudomonas fluorescens NCIMB 10586
noic acid [9-HN]) [2–4] (Figure 1). Pseudomonic acid B
(8%) has an additional hydroxyl group at C8 [4], pseu-
domonic acid C (2%) has a double bond in place of
A. Kassem El-Sayed,1,3 Joanne Hothersall,1
Sian M. Cooper,1 Elton Stephens,1
Thomas J. Simpson,2 and Christopher M. Thomas1,*
1School of Biosciences the epoxide group at C10-C11 [5], and pseudomonic
acid D (2%) has an unsaturated fatty acid side chainUniversity of Birmingham
Edgbaston with an alkene group at C4-C5 [6]. Novel pseudomonic
acid analogs have also been isolated from marine organ-Birmingham B15 2TT
2 School of Chemistry isms, e.g., Altermonas sp. SANK 73390 [7].
Mupirocin is used to control S. aureus, particularlyUniversity of Bristol
Cantock’s Close methicillin-resistant S. aureus (MRSA), when other anti-
biotics are ineffective. It competitively inhibits bacterialBristol BS8 1TS
United Kingdom isoleucyl-tRNA synthase (IleRS) [8] by interaction of the
methyl end of MA, which has the same carbon skeleton
as isoleucine, with the amino acid binding site of IleRS,
while the rest of the MA part and/or C9 side chain inter-Summary
acts with the ATP binding site [9]. Formation of Ile.tRNA
is blocked, thus inhibiting protein synthesis. Despite lowThe polyketide antibiotic mupirocin (pseudomonic
acid) produced by Pseudomonas fluorescens NCIMB affinity for mammalian IleRS [10], mupirocin can only be
used topically because it is quickly inactivated in the10586 competitively inhibits bacterial isoleucyl-tRNA
synthase and is useful in controlling Staphylococcus serum by hydrolysis of the ester linkage between MA
and 9-HA. Ninety-five percent is also serum bound, re-aureus, particularly methicillin-resistant Staphylococ-
cus aureus. The 74 kb mupirocin biosynthesis cluster sulting in poor bioavailability [11]. Resistance to mupi-
rocin is also spreading due to a gene for a mupirocin-has been sequenced, and putative enzymatic func-
tions of many of the open reading frames (ORFs) have insensitive IleRS [for review, see 12]. Manipulation of
mupirocin biosynthesis may make more versatile vari-been identified. The mupirocin cluster is a combination
of six larger ORFs (mmpA-F), containing several do- ants that are active against resistant strains and may
produce novel structures with completely different ac-mains resembling the multifunctional proteins of poly-
ketide synthase and fatty acid synthase type I systems, tivities.
Polyketide biosynthesis occurs by a process similar toand individual genes (mupA-X and macpA-E), some of
which show similarity to type II systems (mupB, mupD, fatty acid biosynthesis. A simple carboxylic acid starter
unit, typically acetate or propionate activated as a CoAmupG, and mupS). Gene knockout experiments dem-
onstrated the importance of regions in mupirocin pro- thioester, is transferred to the cysteine group of a
-ketoacyl synthase (KS), and a dicarboxylic acid ex-duction, and complementation of the disrupted gene
confirmed that the phenotypes were not due to polar tender unit, usually a malonate or methyl malonate CoA
thioester, is transferred to the thiol group of the phos-effects. A model for mupirocin biosynthesis is pre-
sented based on the sequence and biochemical evi- phopantetheine arm of an acyl carrier protein (ACP).
These are joined by a decarboxylative condensationdence.
catalyzed by KS and remain covalently attached to ACP
as a thioester. The -carbonyl group of the resultingIntroduction
intermediate may be partially or fully reduced by the
activities of -ketoacyl reductases (KR), dehydratasesAnalysis of genes for polyketide biosynthesis has re-
vealed rules that add to our ability to predict how certain (DH), and enoyl reductases (ER) acting sequentially or
left unreduced. The growing chain is transferred fromcompounds are synthesized and to manipulate the bio-
synthetic genes to generate novel variants with poten- the ACP back to a KS, and further rounds of elongation
and reduction occur to achieve the full-length polyketidetially new and useful properties [1]. By analyzing addi-
chain, which may be further modified by the activitytional biosynthetic pathways in diverse species, the
of tailoring enzymes. The completed chain is typicallyrules can be made more general and the repertoire of
released from the polyketide synthase (PKS) by hydroly-tools for combinatorial biosynthesis expanded.
sis catalyzed by a terminal thioesterase (TE). The cata-Mupirocin is a mixture of polyketides (pseudomonic
lytic sites of PKSs may be encoded either by distinctacids) produced by P. fluorescens NCIMB 10586. Pseu-
proteins (type II) or by domains within large multifunc-domonic acid A, which accounts for 90% of the mixture,
tional proteins (type I). These may be used iteratively,consists of a C17 unit (monic acid [MA]) thought to be
as for aromatic polyketides, or, in the case of complexderived from an unsaturated polyketide containing a
polyketides, may be modular, with each module encod-pyran ring, and a C9 saturated fatty acid (9-hydroxynona-
ing a specific round of condensation and reduction. In
some systems, a methyl group may be introduced at
*Correspondence: c.m.thomas@bham.ac.uk
the -ketothioester stage by the action of a C-methyl3Present address: Botany Department, Faculty of Science (Dam-
transferase (MeT), which transfers the methyl group fromietta), University of Mansoura, Damietta El-Gededa, PO Box 34517,
Egypt. S-adenosyl-methionine (SAM) onto the activated meth-
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Figure 1. Structure of Pseudomonic Acid A
Pseudomonic acid consists of a C17 unit
(monic acid) derived from an unsaturated
polyketide containing a pyran ring, and a C9
saturated fatty acid (9-hydroxynonanoic
acid).
ylene of the -ketothioester. In fungal type I systems, (see http://www.chembiol.com/cgi/content/full/10/5/
419/DC1 or write to chembiol@cell.com for a PDF).the MeT is encoded as part of the PKS gene.
Mupirocin biosynthesis has previously been studied The whole chromosomal segment was sequenced in
both directions, and the sequence of the 74 kb mupirocinby classical methods such as feeding of isotopically
labeled substrates. This showed that pseudomonic acid biosynthesis cluster has been deposited with GenBank
(AF318063). The GC content ranges from 50% to 68%A is derived from a linear combination of acetate-derived
units, except for C16 and C17, which are derived from and is on average 61%, typical of other Pseudomonads
(60%) [17]. Open reading frames (ORFs) were identifiedmethyl of SAM, and C15, which has been proposed to be
derived from acetate via 3-hydroxy-3-methylglutarate using a genomic codon preference table of P. fluo-
rescens (www.kazusa.or.jp/codon) and GCG program(HMG) [13, 14]. The oxygen atoms attached to C1, C5,
C7, C13, and C9 are acetate-derived, and the C1 ester [18]. All the ORFs identified use ATG (86%), GTG, (11%),
or TTG (3%) as the start codon preceded by good ribo-linkage is proposed to be formed from condensation of
MA and 9-HA subunits [15]. some binding sites. All ORFs showed 60% or higher
GC content except for mupI (51%) and mupR (50%),Transposon mutagenesis, gene cloning, and reverse
genetics identified a65 kb region involved in mupirocin encoding quorum regulators of mup gene expression
[19]. Thus, these genes may have been relatively re-biosynthesis [16]. In this paper we describe the se-
quence of the cluster, its predicted enzyme activities, cently recruited. Alignments of the DNA sequence and
amino acid sequence of all six frames were performedand a model for the mupirocin biosynthetic pathway
that is largely supported by the sequence. using FASTA and BLAST to identify putative functions
of the ORFs, with the predictions shown in Table 1 and
Figure 2. The first 40.5 kb contains two individual genes
Results and Discussion (mupA and mupB) and four large ORFs (mmpA, B, C,
and D) whose predicted products are referred to as
Cloning and Sequencing of a Mupirocin mupirocin multifunctional proteins (Mmp).
Biosynthesis Cluster We previously identified a putative MupR box up-
Deletion derivatives of two previously described plas- stream of mupA that may activate transcription from the
mids, pBROC130/131 [16], were constructed and used mupA promoter [19]. Transcription from this promoter
for DNA sequencing. A strategy involving suicide vector may proceed across the whole mup gene cluster since
pAKE100 or pCAW5.3 was then used to clone chromo- all except three of the ORFs identified (mupF, mupP, and
somal fragments extending upstream and downstream mupI) run in the same direction as mupA. No potential
from this region. Fragments from already cloned chro- internal promoters were identified by similarity either to
mosomal DNA were inserted into a suicide vector, and consensus sequences for any of the known sigma fac-
the derivative was transferred into P. fluorescens by tors or to the putative MupR binding site.
biparental mating. Cointegrants with the plasmid in- Upstream of the putative mupA promoter region, we
serted by homologous recombination into the chromo- found genes for tRNAVal and tRNAAsp. Southern blottingsome were selected. Chromosomal DNA was isolated revealed that mup DNA was not present in P. fluorescens
and fragmented by digestion with a restriction enzyme SBW25, which does not produce mupirocin, but DNA
that does not cut in the vector or the DNA already cloned. on the other side of the tRNA cluster was present in
The resulting DNA fragments were circularized by liga- SBW25. This interpretation has recently been confirmed
tion at dilute DNA concentrations and transformed into by alignments with a contiguous sequence from the
Escherichia coli HB101. Clones containing the suicide ongoing P. fluorescens SBW25 genome sequencing
vector and the largest upstream or downstream chromo- project (www.sanger.ac.uk/Projects/P_fluorescens/).
somal fragments were selected and either subcloned or This suggests that the mup cluster may be an insertion
used directly for sequencing. This procedure was used integrated by recombination at tRNA genes as observed
repeatedly in a step-wise fashion to perform a chromo- for a number of phage and mobile elements [20].
some walk. A cointegrant (P. fluorescens 33.2:5.8) con-
structed previously [16] was used to clone the chromo-
somal DNA at the other end of the mupirocin cluster. Domains Typical of Polyketide Production
Encoded in the mup ClusterFinally, the gap between the two blocks was obtained by
PCR. Details of the clones encompassing the mupirocin The cluster contains various individual genes (mupE, F,
J, K, Q, and U and macpA, B, C, D, and E ) and sixbiosynthesis cluster are available as supplemental data
P. fluorescens Mupirocin Biosynthesis
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Figure 2. Organization of Mupirocin Biosynthesis Cluster
multifunctional genes (mmpA, B, C, D, E, and F ) with due within a (t/a/s)(a/m)Csssl motif, except KS1 (am-
Cagg). The two His residues are also present, exceptpredicted type I PKS and fatty acid synthase (FAS) func-
tions. In general, the closest relatives of the mup do- for the first His residue of KS1 and KS9, which are Gln
and Ser, respectively.mains are found in genes for polyketide biosynthesis
in Bacillus subtilis [21] or erythromycin biosynthesis in -Ketoacyl Reductases
Six potential -ketoacyl reductase (KR) domains wereSaccharopolyspora erythraea, [22] as listed in Table 1.
Some of the individual genes (mupB, mupD, mupG, and identified. KR domains possess a potential NADP(H)
binding motif. KR1 matches a motif (GxGxxAxxxA) pres-mupS) show similarity to PKS genes of type II systems.
It therefore seems that the mupirocin PKS is a combina- ent in the rapamycin and erythromycin KRs [22, 24],
while Ala replaces the first Gly of KR2. The KR3-KR6tion of both type I and type II PKS systems. Those genes
and domains typical of polyketide production identified motifs (GxGxxGxxxT/A/C) are similar to the niddamycin
KR motif [27].within the mup cluster are summarized below.
Acyltransferases Dehydratases
Four potential dehydratase (DH) domains were identi-Only two potential acyltransferase (AT) domains were
identified, both located in MmpC. Both AT1 and AT2 fied. DH1 and DH3 possess a motif (HxxxGxxxxP) found
in other DH domains of erythromycin, rapamycin, andshow similarity to AT from type I systems such as DEBS,
responsible for production of the 6-deoxyerythronolide niddamycin [22, 28]. The DH4 motif contains Ala instead
of Pro, while DH2 contains Asp and Ala instead of Glyaglycone of erythromycin in S. erythraea (27%–29%
identity at the amino acid level). AT2 shows higher iden- and Pro, respectively. We predict that DH2 is unlikely
to be active (see Figure 3A).tity (40%) with FabD, which possesses malonyl-CoA-
ACP transacylase activity [23]. AT domains of PKS and Methyltransferases
Two potential methyltransferase (MeT) domains wereFAS systems can be divided into two main groups ac-
cording to six conserved motifs. The first includes identified within MmpD. Both MeT1 and MeT2 possess
the conserved motif (LexGxGxG) found in MeT domainsmalonyl-CoA- and acetyl-CoA-dependent AT, and the
second includes methylmalonyl-CoA- and propionyl- involved in C-methylation of lovastatin by Aspergillus
terreus [29] and yersiniabactin by Yersinia pestis [30].CoA-dependent AT [24–26]. AT1 and AT2 show similarity
to both types but are more similar to each other than Acyl Carrier Proteins
Sixteen potential acyl carrier proteins (ACPs) were iden-to other members of either of the subgroups.
-Ketoacyl Synthases tified: 11 within Mmps and 5 present as individual genes.
The characteristic ACP motif GxDS [24] with the essen-Ten potential -ketoacyl synthase (KS) domains of the
PKS type I system were identified. KS domains contain tial serine was present in Mmp ACP1-11 and MacpA
and B, but MacpC, D, and E have the serine residuean active site Cys within a taCsssl motif and two His
residues at 135 and 175 aa downstream of the Cys within GANS, GLSS, and KINS, respectively. An unusual
but not unique feature of the mup pathway is the exis-active site [24]. All mup KS domains contain a Cys resi-
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tence of a tandem ACP doublet (ACP3 and 4) and a biosynthesis cluster and one elsewhere in the chro-
mosome.tandem ACP triplet (ACP5, 6, and 7). They may hold
multiple substrates prior to condensation or provide in- The ability of MupM to confer mupirocin resistance
was demonstrated by pAKE900, which contains mupMcreased throughput at rate-limiting steps in the pathway.
Tandem ACPs have also been observed in various type under the control of the lacZ operon, raising the MIC of
E. coli DH5 to mupirocin from 30 to 250 g·ml1.I iterative fungal PKS, e.g., WA, a naphthopyrone syn-
thase of Aspergillus nidulans in which both ACPs func-
tion but only one is required [31].
Gene Knockouts across the mup Region GenerateThioesterase
the Mup PhenotypeThe C-terminal end of MmpB showed significant similar-
Gene knockouts were constructed to confirm regionsity with thioesterase (TE) domains and contains the motif
needed for mupirocin production (Table 2). DerivativesGxSxG found in other TE domains but does not contain
of suicide vectors pAKE603/604 with pairs of arms ata second conserved motif GxH [22, 32].
least 500 bp in size flanking in-frame deletions within
selected genes were introduced into P. fluorescens by
biparental mating and homologous recombination. De-Potential Auxiliary and Tailoring Functions
letions were constructed either by restriction digestionSpecific to Mupirocin Biosynthesis
of a chromosomal fragment or ligation of two PCR frag-Other putative gene functions were identified within the
ments flanking the region to be deleted. Cointegrantsmup cluster (Table 1). MupQ and MupU show similarity
with an inserted plasmid were passaged to medium con-to proteins that activate their substrates by covalently
taining 5% sucrose to select for the products of plasmidbinding AMP to a carboxylic side group, e.g., long chain
excision by homologous recombination. These coloniesfatty acid-CoA synthases. Mup A shows similarity to a
were screened by PCR to identify those with a mutation.subunit of LuxA of Vibrio harveyi, and this could repre-
Knockout phenotype was determined by bioassay forsent part of an FMNH2-dependent oxygenase. MupB
mupirocin production (Table 2). Selected knockoutsand MupG show similarity to FabH (KASIII) and to FabB
were tested for complementation by the wild-type gene(KASI), respectively, which are 3-oxoacyl-ACP syn-
expressed in trans to confirm that the phenotypes ob-thases. Two 3-oxoacyl-ACP reductases, MupD and
served were due to the specific deletion in that geneMupS, were also identified. MupH shows similarity to
and not polar effects.many proteins possessing HMG-CoA synthase activity
KRI was deleted from MmpA (10586KR1); TE wasand is suggested to play a role in introducing the methyl
deleted from MmpB (10586TE); and AT2 was deletedgroup at C15 (see below). MupJ and MupK both show
from MmpC (10586AT2). MupT was also deletedgood similarity to enoyl-CoA hydratases, and MupE to
(10586MupT). Each of these deletions resulted in lossshows good similarity enoyl reductases. Several other
of detectable antibiotic activity by comparison with thepotential oxygenases and reductases were also identi-
negative control SBW25 by bioassay and HPLC analysis.fied within the second half of the cluster: MupO is pro-
Wild-type P. fluorescens NCIMB 10586 has a peak with aposed to be a cytochrome P450, MupW a dioxygenase,
retention time of 20.2 min (Figure 4A), which was purifiedMupT a ferredoxin dioxygenase, MupC an NADH/
and shown to have antibiotic activity. This is comparableNADPH oxidoreductase, and MupF a ketoreductase.
to the retention time of mupirocin standard (20.1 min)MupL is a putative hydrolase, and MupV a putative oxi-
(Figure 4C). 10586KR1 did not have a peak in thisdoreductase. However, their possible functions are un-
region (Figure 4B) and is typical of all the mutants re-clear. The C-terminal of MmpE shows similarity with
ported herein (data not shown). None of the mutantshydroxylases, and MupX with amidases and hydrolases.
appeared to excrete detectable biosynthetic intermedi-MupN shows similarity with regulatory binding proteins
ates. The most obvious possibility was that MA mightsuch as Lpa14 from B. subtilis, which is required for
accumulate. The MA standard runs at 9.7 min, and nothe expression and regulation of genes for synthesis of
peak appeared here in any of the mutants. However, itcyclic lipopeptides surfactin and iturin A [33]. MupR and
should be noted that the profiles initially analyzed wereMupI have been described before [19] and are referred
of culture supernatant rather than cell lysates, so if MAto above.
accumulated in the cytoplasm, we would not have de-
tected it. The main purpose of the HPLC analysis was
to confirm the disappearance of the mupirocin peak.Resistance to Mupirocin Is Encoded
within the Cluster Knockouts of MupR and MupI were shown to be essen-
tial for mupirocin biosynthesis [19].The target for mupirocin is isoleucyl t-RNA synthetase
(IleRS). MupM showed significant similarity with several KS1 may be inactive due to differences from other KS
in the consensus motifs (amCagg cf taCsssl; and Gln cfmupirocin-resistant IleRS (see Table 1). Another IleRS
(IleS; P18330) has previously been cloned from P. fluo- His at 135 aa). However, both a deletion of this region
(10856KS1) and a point mutation of the proposed KS1rescens NCIMB 10586 and shown to confer mupirocin
resistance [9]. MupM and IleS both contain the consen- active site (10586KS1,C196A) abolished detectable
mupirocin production.sus motifs for type I aminoacyl-tRNA synthetases [34]
(HIGH and KMSKS; HYGH and KMSKR, respectively), Complementation of AT2 was carried out by placing
a cloned fragment encoding MmpC in trans in P. fluo-but only show 29% identity to each other. Thus there
may be two distinct mupirocin-resistant IleRS genes rescens NCIMB10586AT2. To do this, a 3.7 kb EcoRI-
ClaI fragment containing mmpC was cloned into an IncQwithin P. fluorescens NCIMB 10586, one within the mup
P. fluorescens Mupirocin Biosynthesis
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Figure 3. Models for Biosynthesis of Mupirocin Components
(A) Mupirocin biosynthesis model.
(B) HMG-based model for incorporation of the C15 methyl group in monic acid.
(C) 9-hydroxynonanoic biosynthesis model. (Ci) HMG starter unit formed from condensation of acetate and acetoacetate catalyzed by MupH
and extended by two malonate condensations followed by removal of 3-methyl and hydroxyl groups. (Cii) Alternatively, a 3-hydroxyproprionate
starter unit may be extended by three malonate condensations. ACP 	 acyl carrier protein; AT 	 acyl transferase; DH 	 dehydratase; HMG 	
3-hydroxy-3-methylglutaric acid; KS 	 ketosynthase; MupE 	 enoyl reductase; MupH 	 HMG-CoA synthase; TE 	 thioesterase.
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Figure 4. HPLC Analysis of Mupirocin Production
(A) P. fluorescens (NCIMB 10586).
(B) NCIMBKR1.
(C) Mupirocin standard (100 ng).
plasmid under the control of the tac promoter (pJH3).
The phenotype of AT2 was restored to wild-type by
pJH3 without induction by IPTG but not after induction
with 
0.1 mM IPTG, so excess expression of this gene
may block biosynthesis. Similarly, 10586MupT was
complemented by a 351 bp PCR fragment of mupT
(pSCT) after induction by IPTG (0.5 mM). These results
indicate that the phenotypes of the knockout result from
inactivation of the specific genes targeted.
A Possible Pathway for Biosynthesis of Mupirocin
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It has been demonstrated that mupirocin is derived
mainly from acetate and proposed that separate PKS
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and FASs are involved in its assembly from MA and a C10 structure (3). The fourth condensation step is cata-
9-HA via an esterification [4, 15]. Based on other PKS/ lyzed by MmpD KS8 (module 4), in the same module,
FAS systems, a plausible biosynthetic pathway for MA followed by reduction by KR6, producing a C12 struc-
is proposed in Figures 3A and 3B. ture (4).
Unlike the erythromycin biosynthesis pathway, which Further assembly of MA may be continued by MmpA.
is colinear with the gene order in the cluster [35], the A fifth condensation of malonate catalyzed by MmpA
mup genes do not appear to follow a simple progression KS2 (module 5) followed by ketoreduction by KR1, in
and lack an obvious loading domain, which should cata- the same module, should produce a C14 structure (5). The
lyze the covalent attachment of an activated starter unit sixth condensation catalyzed by MmpA KS3 (module 6)
to the first KS domain of a PKS. No AT domains were and leaving the keto unreduced should produce a C16
identified within the condensation modules themselves, -ketothioester (6). However, this does not predict a
so the AT domains of mmpC may perform the task of function for KS1. Although KS1 may not have a com-
loading and transferring the growing polyketide chain pletely normal function since it has Gln instead of His in
to each KS, or other unidentified transferase activities its proposed active site, it is necessary for biosynthesis
may be involved. rather than being redundant, as indicated by the fact
We predict that biosynthesis starts with production that mutation of KS1 gives a Mup phenotype. Thus,
of the C12 pentaketide moiety (4, from Figure 3A) by KS1 may be acting as a pseudoloading module either
MmpD, which then acts as a primer for biosynthesis of to facilitate the transfer of the pentaketide intermediate
the remainder of the MA polyketide precursor (6) di- between MmpD and MmpA or even to help load the
rected by MmpA, and possibly MupH (see below). The starter of the process at MmpD KS5.
location of MmpC (AT1 and AT2) immediately before The incorporation of a methyl group at C15 could be
MmpD may be significant in this regard. Indeed, if the via condensation of an acetate unit at the -keto group
segment from mmpA to mmpD were looped out as a of structure (6) by the putative HMG-CoA synthase
circle, the proposed pathway would be colinear. MmpB, (MupH) (Figure 3B). Similar reactions have been ob-
with additional enzyme activities provided from other served during the biosynthesis of, for example, virgin-
parts of the mup gene cluster, may synthesize 9-HN. iamycin [37], myxopyronins [38], and aurantins [39]. The
MmpD should encode sequential modules that cata- resulting carboxylic acid group would undergo decar-
lyze the first four condensations. The following descrip- boxylation followed by dehydration, possibly involving
tion refers to carbons by number in the conventional activation of the hydroxyl group, for example, by phos-
diagrams of mupirocin structure (Figure 1). Starter and phorylation, producing a terminal alkene CH2 group. The
extender units could be activated by MupU and MupQ, double bond would rearrange in conjugation with the
which show similarity to acyl-CoA synthases that acti- thioester carbonyl, presumably by an isomerase-depen-
vate substrates by linking their carboxyl group to the dent reaction producing the C17 -unsaturated thioes-
phosphoryl group of AMP. The activated substrate is ter (7) in which the 15-methyl group is derived from the
then transferred to Coenzyme A (CoA). Mupirocin bio- methyl carbon of the cleaved acetate unit.
synthesis could start with one of the ATs transferring Further modifications are required to generate MA
an activated acetyl starter unit from CoA to the 4-phos- from structure (7), which would include oxidation and
phopantetheine arm of ACP8 and then to the thiol group reduction to create the epoxide group and tetrahydropy-
of the active cysteine of KS5 (both in the proposed ran ring. These reactions could be catalyzed by MupO
module 1 of MmpD) in a decarboxylative step. An acti- (P450), MupC (NADH oxidoreductase), MupT (ferredoxin
vated malonyl extender could then be transferred to the dioxygenase), and/or MupW (dioxygenase).
vacant ACP8. Alternatively, an activated acetyl unit may 9-Hydroxynonanoic Acid
be transferred directly to KS5. KS5 is proposed to cata-
It is much more difficult to predict the source of 9-HN,
lyze the first decarboxylative condensation step of ace-
which is a C9 fully saturated fatty acid chain. This maytate and malonate, followed by addition of a methyl
be synthesized by a single PKS/FAS with full reduction
group from SAM at C12 by MeT1 (in the proposed mod-
of the keto groups by ketoreduction, dehydration, andule 1 of MmpD) and ketoreduction catalyzed by KR3, in
enoyl reduction. One possibility is that MupH (HMG-the same module, producing a C5 structure (1). DH2, in CoA synthase) may catalyze the condensation of acetatethe same module, is probably nonfunctional due to its
and acetoacetate to generate HMG, which would beputative consensus active site (HxxxDxxxxA) differing
chain-extended by two condensations of malonate moi-from other DHs (HxxxGxxxxP). Such nonfunctional do-
eties followed by removal of the 3-methyl and hydroxylmains have been observed in several modular PKSs,
groups and reduction of the distal carboxyl group (Fig-e.g., RAPS 1 and 2 in rapamycin biosynthesis in Strepto-
ure 3Ci). However, studies with doubly 13C-labeled HMGmyces hygroscopicus [24] and in pltD from the pyolut-
showed no intact incorporation [15]. Formally, 9-HNerin biosynthesis cluster in P. fluorescens Pf-5 [36]. The
could be formed from a 3-hydroxypropionate startersecond cycle of condensation is predicted to be cata-
unit by three malonate condensations catalyzed by alyzed by MmpD KS6 (module 2) and followed by ketore-
dedicated FAS (Figure 3Cii). Preliminary evidence hasduction and then dehydration catalyzed by KR4 and
been obtained for this by synthesis and feeding ofDH3, respectively (of the same module), producing a C7
[1-13C]-3-hydroxypropionate, which resulted in specificstructure (2). The third condensation reaction corre-
enrichment (2.5-fold) of C7 [40].sponds to MmpD KS7 (module 3), followed by addition
If 3-hydroxypropionate is involved, there are severalof a methyl group from SAM at C8 by MeT2, reduction,
ORFs of unknown function that could be involved. Oneand dehydration of the keto group by KR5 and DH4,
respectively (again within the same module), producing candidate PKS/FAS for iterative incorporation of the
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Table 3. Plasmids Used or Constructed During This Study
Reference/
Plasmid Size (kb) Replicon Genotype/Phenotype Source
pAKE100 4.9 pMB1 Apr, Kmr, oriT [19]
pAKE603 5.9 pMB1 Apr, oriT, lacZ, sacB This study
pAKE604 7.2 pMB1 Apr, Kmr, oriT, lacZ, sacB [19]
pBROC130 18.7 ColE1 Apr, Kmr, Tn5 [16]
pBROC131 15.6 ColE1 Apr [16]
pCAW5.3 4.9 pMB1 Apr, Kmr, oriT [16]
pDM1.2 14.5 IncQ Smr, Tcr [53]
pGBT400 11.6 IncQ Smr, oriT, tacp [54]
pJH10 14.5 IncQ pOLE1 IncC1 deleted, with EcoRI-SacI polycloning site, This study
Tcr from pDM1.2
pOLE1 12.7 IncQ pGBT400 with IncC1, Smr, oriT, tacp [54]
pUC18 2.7 pMB1 Apr, lacZ, polylinker [55]
three malonates could be MmpB, which contains KS4, from the type I modules; the multiple tandem ACPs;
and the single TE despite two predicted products. OurKR2, DH1, ACP5-7, and TE. However, MmpB does not
contain an enoyl reductase (ER) domain. MupE shows gene knockouts so far have shown all predicted genes
to be necessary for mupirocin production, and this issequence similarity to ER and therefore could catalyze
the final reduction step of 9-HN. Precedence for this not due to polar effects, since complementation by
the intact ORF has been possible where attempted.possibility is found in lovastatin biosynthesis, where the
proper functioning of the lovD nonaketide synthase Current characterization of products of mutant strains
or subcloned segments of the pathway should allow(LNKS) requires the accessory lovC protein [41]. The
unusual ACP triplet within MmpB may be involved in a tighter link between the biosynthetic pathway and
gene sequence to be established. Nevertheless, areceiving 3-hydroxypropionate and three malonate mol-
ecules or other intermediates. It is also possible that the plausible order of biosynthetic steps and genes can
be constructed at least for MA and provides a workingorganism makes use of the ER used in endogenous fatty
acid metabolism, as has been suggested for prodigiosin model to underpin future experimental design. The
apparent wealth of tailoring enzymes suggests greatbiosynthesis in Streptomyces coelicolor [42].
The TE domain at the end of MmpB would fit with this potential for mup genes as part of the repertoire cur-
rently available for combinatorial genetics in polyke-model for 9-HN biosynthesis being involved with release
of either 9-HN or mupirocin or with esterification of 9-HN tide drug discovery.
and MA. Alternatively, the C9 moiety may be derived
from a pathway outside of the cluster. It could also Experimental Procedures
involve other enzymes from within the cluster, e.g.,
Bacterial Strains and PlasmidsmupB and mupG (3-oxoacyl-ACP synthases), and mupD
P. fluorescens NCIMB 10586 [16] was used as the wild-type mupi-and mupS (3-oxoacyl-ACP reductases) for which roles
rocin producer, and SBW25 [17] was used as a nonproducer ofhave not been assigned.
mupirocin. E. coli strains DH5 [43] and NEM259 (SupE SupF hsdR
met trpR, N.E. Murray, University of Edinburgh) were used for plas-
mid transformation and propagation; S17-1 [44] was used to mobi-Biosynthesis of Other Pseudomonic Acids
lize suicide and expression plasmids into P. fluorescens; and HB101Pseudomonic acid B contains a hydroxyl group at C8,
[45] was used for transformation to recapture suicide plasmids con-
which may be a result of further oxidative modification. taining large chromosomal fragments. B. subtilis 1064 [46] was used
Pseudomonic acid C has an alkene at C10-C11 instead in bioassays to monitor mupirocin production. Other bacterial
of an epoxide, which may be due to lack of processing strains constructed in this study are shown in Table 2, and plasmids
used or constructed during this work are listed in Tables 2 and 3.by MupO (putative P450 oxygenase). Pseudomonic acid
D has an unsaturated C9 chain (alkene at C4-C5), which
may arise from the second malonate condensed with Growth and Culture Conditions
E. coli strains were grown at 37C in L broth [47] and L agar (L broth3-hydroxy-propionate not being fully reduced by ER.
supplemented with 1.5%, w/v agar) supplemented with appropriate
antibiotics. P. fluorescens strains were grown at 30C in L broth
Significance and L agar. For plasmid maintenance and selection of antibiotic-
resistant transformants, media were supplemented with appropriate
antibiotic concentrations as follows: 100 g ampicillin ml1, 50 gThe gene cluster we have sequenced may be a pheno-
kanamycin ml1, 150 and 300 g penicillin G ml1 in liquid andtypic island that could carry mupirocin biosynthesis
solid medium, respectively, 600 g mupirocin ml1, and 15–25 g
and resistance from one strain to another. There tetracycline.HCL ml1.
seems to be an excess of coding capacity in the mup
cluster for synthesis of the whole of mupirocin and its
DNA Isolation and Manipulationrelatives. There also seem to be some notable fea-
Plasmid DNA extraction was performed by the alkaline SDS method
tures: its initial lack of an obvious linear relationship of Birnboim and Doly [48] with slight modifications [49], or with
between gene order and biosynthetic pathway; the Wizard Plus SV Mini Preps DNA Purification Systems (Promega).
Genomic DNA was isolated from P. fluorescens using a yeast DNAprovision of only two AT domains, which are separate
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mini-prep kit (Nucleon, Tepnel Life Sciences). DNA was digested Received: September 24, 2002
Revised: March 31, 2003with appropriate restriction enzymes (MBI Fermentas). DNA was
analyzed by standard agarose gel electrophoresis [50]. Extraction Accepted: April 8, 2003
Published: May 16, 2003of DNA from agarose was performed using GeneClean kit (Bio101).
Sticky ended DNA was blunt-ended using DNA polymerase I, large
(Klenow) fragment (New England Biolabs). Ligations were performed References
using T4 DNA ligase [50]. PCR fragments were cloned into a T-tailed
vector pGEM-TEasy (Promega). Competent E. coli cells were trans- 1. Staunton, J., and Wilkinson, B. (2001). Combinatorial biosynthe-
sis of polyketides and nonribosomal peptides. Curr. Opin.formed with plasmid DNA using the method of Cohen et al. [51].
Chem. Biol. 5, 159–164.
2. Fuller, A.T., Mellows, G., Woodford, M., Banks, G.T., Barrow,Suicide Mutagenesis of P. fluorescens
K.D., and Chain, E.B. (1971). Pseudomonic acid: an antibioticBiparental mating was carried out to mobilize the suicide plasmid
produced by Pseudomonas fluorescens. Nature 234, 416–417.derivatives and expression vectors from E. coli S17-1 to P. fluo-
3. Chain, E.B., and Mellows, G. (1974). Structure of pseudomonicrescens as follows. A mixture of late exponential phase cultures
acid, an antibiotic from Pseudomonas fluorescens. J. Chem.of E. coli S17-1, containing the relevant plasmid (0.5 ml), and P.
Soc. Chem. Commun., 847–848.fluorescens (0.5 ml) were filtered on to a 0.45 m sterile Millipore
4. Chain, E.B., and Mellows, G. (1977). Pseudomonic acid. Part 1.filter. The filter was placed on L agar overnight at room temperature.
The structure of pseudomonic acid A, a novel antibiotic pro-The mating mixture was resuspended in sterile saline solution (1
duced by Pseudomonas fluorescens. J. Chem. Soc. Perkinml), and aliquots (100l) were spread on either L agar, supplemented
Trans. 1, 294–309.with the appropriate antibiotic to select for the presence of the
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